The gap between disease pathology and the identification and roles of causative genes is a major problem of the genomic revolution. Another difficulty is the selection of target genes with the best changes of making the long journey from the bench to the clinic. Antisense oligonucleotides (oligos) for gene functionalization (determining gene function) is of course vital to gene therapty.